Michael P. D’Erasmo

450 total citations
18 papers, 328 citations indexed

About

Michael P. D’Erasmo is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Michael P. D’Erasmo has authored 18 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Organic Chemistry. Recurrent topics in Michael P. D’Erasmo's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Synthetic Organic Chemistry Methods (3 papers). Michael P. D’Erasmo is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Synthetic Organic Chemistry Methods (3 papers). Michael P. D’Erasmo collaborates with scholars based in United States, South Africa and Canada. Michael P. D’Erasmo's co-authors include Ryan P. Murelli, Stuart F.J. Le Grice, John E. Tavis, Marvin J. Meyers, Chad A. Lewis, Emilio Gallicchio, Jian‐kang Jiang, Gaofeng Lu, Gerard D. Wright and John A. Beutler and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael P. D’Erasmo

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael P. D’Erasmo United States 10 117 115 110 70 63 18 328
Inna L. Karpenko Russia 16 186 1.6× 194 1.7× 282 2.6× 217 3.1× 22 0.3× 43 607
David D. Deininger United States 9 88 0.8× 107 0.9× 216 2.0× 186 2.7× 13 0.2× 14 417
Michael J. Bohanon United States 7 109 0.9× 38 0.3× 114 1.0× 127 1.8× 39 0.6× 8 327
Ying-Kai Wang United States 12 71 0.6× 186 1.6× 134 1.2× 226 3.2× 22 0.3× 22 426
Nicola Zonta United Kingdom 7 259 2.2× 48 0.4× 133 1.2× 114 1.6× 51 0.8× 10 473
Massimiliano La Colla Italy 11 221 1.9× 76 0.7× 127 1.2× 208 3.0× 12 0.2× 16 434
Ray Ranken United States 8 323 2.8× 44 0.4× 252 2.3× 50 0.7× 15 0.2× 10 554
Noreena L. Sweeney United States 10 61 0.5× 62 0.5× 123 1.1× 96 1.4× 8 0.1× 17 336
Steven R. Mathieu United States 6 72 0.6× 66 0.6× 85 0.8× 116 1.7× 23 0.4× 8 255
Christopher J. Yarnold United Kingdom 7 98 0.8× 93 0.8× 119 1.1× 61 0.9× 17 0.3× 9 270

Countries citing papers authored by Michael P. D’Erasmo

Since Specialization
Citations

This map shows the geographic impact of Michael P. D’Erasmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. D’Erasmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. D’Erasmo more than expected).

Fields of papers citing papers by Michael P. D’Erasmo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. D’Erasmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. D’Erasmo. The network helps show where Michael P. D’Erasmo may publish in the future.

Co-authorship network of co-authors of Michael P. D’Erasmo

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. D’Erasmo. A scholar is included among the top collaborators of Michael P. D’Erasmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. D’Erasmo. Michael P. D’Erasmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fritzemeier, Russell G., Nicholas S. Akins, Pantelis Antonoudiou, et al.. (2025). Thienopyrimidinone Derivatives as a GluN2B/C/D Biased, Positive Allosteric Modulator of the N-Methyl-d-Aspartate Receptor. Journal of Medicinal Chemistry. 68(9). 9303–9322. 1 indexed citations
2.
Fritzemeier, Russell G., et al.. (2025). Rotamer-Controlled Self-Immolative Linkers Enable Tunable Release of Neurosteroid Oxime Prodrugs. ACS Medicinal Chemistry Letters. 16(10). 2022–2031.
3.
D’Erasmo, Michael P., Savita K. Sharma, Adriaan E. Basson, et al.. (2024). Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis. Journal of Medicinal Chemistry. 67(20). 18204–18220.
4.
Toti, Kiran S., Michael P. D’Erasmo, Madhuri Dasari, et al.. (2023). Expanding the toolbox of metabolically stable lipid prodrug strategies. Frontiers in Pharmacology. 13. 1083284–1083284. 4 indexed citations
5.
Dasari, Madhuri, Stephen C. Pelly, Jiafeng Geng, et al.. (2023). Discovery of 5′-Substituted 5-Fluoro-2′-deoxyuridine Monophosphate Analogs: A Novel Class of Thymidylate Synthase Inhibitors. ACS Pharmacology & Translational Science. 6(5). 702–709. 4 indexed citations
6.
Fritzemeier, Russell G., Michael P. D’Erasmo, Savita K. Sharma, et al.. (2023). Neurotherapeutic Potential of Water-Soluble pH-Responsive Prodrugs of EIDD-036 in Traumatic Brain Injury. Journal of Medicinal Chemistry. 66(8). 5397–5414. 11 indexed citations
7.
D’Erasmo, Michael P., Madhuri Dasari, Savita K. Sharma, et al.. (2021). ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties. Journal of Medicinal Chemistry. 64(17). 12917–12937. 9 indexed citations
8.
D’Erasmo, Michael P. & Ryan P. Murelli. (2018). Fluorous-Phase Approach to α-Hydroxytropolone Synthesis. The Journal of Organic Chemistry. 83(3). 1478–1485. 9 indexed citations
9.
Ireland, Peter J., John E. Tavis, Michael P. D’Erasmo, et al.. (2016). Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses. Antimicrobial Agents and Chemotherapy. 60(4). 2140–2149. 33 indexed citations
10.
D’Erasmo, Michael P., et al.. (2016). Free Energy-Based Virtual Screening and Optimization of RNase H Inhibitors of HIV-1 Reverse Transcriptase. ACS Omega. 1(3). 435–447. 18 indexed citations
11.
Zhao, Haiyan, Michael P. D’Erasmo, A. Gupta, et al.. (2016). Characterization of the C-Terminal Nuclease Domain of Herpes Simplex Virus pUL15 as a Target of Nucleotidyltransferase Inhibitors. Biochemistry. 55(5). 809–819. 28 indexed citations
12.
Murelli, Ryan P., Michael P. D’Erasmo, Jennifer A. Wilson, et al.. (2016). Synthetic α-hydroxytropolones as inhibitors of HIV reverse transcriptase ribonuclease H activity. MedChemComm. 7(9). 1783–1788. 12 indexed citations
13.
D’Erasmo, Michael P., et al.. (2016). Traceless solid-phase α-hydroxytropolone synthesis. MedChemComm. 7(9). 1789–1792. 10 indexed citations
14.
D’Erasmo, Michael P., et al.. (2016). Discovery and Development of a Three-Component Oxidopyrylium [5 + 2] Cycloaddition. The Journal of Organic Chemistry. 81(9). 3744–3751. 24 indexed citations
15.
Cox, Georgina, et al.. (2014). Inhibition of the ANT(2″)-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones. Bioorganic & Medicinal Chemistry Letters. 24(21). 4943–4947. 40 indexed citations
16.
D’Erasmo, Michael P., William Smith, Alberto Múñoz, et al.. (2014). 7,9-Diaryl-1,6,8-trioxaspiro[4.5]dec-3-en-2-ones: Readily accessible and highly potent anticancer compounds. Bioorganic & Medicinal Chemistry Letters. 24(16). 4035–4038. 3 indexed citations
17.
Lu, Gaofeng, Elena Lomonosova, Xiaohong Cheng, et al.. (2014). Hydroxylated Tropolones Inhibit Hepatitis B Virus Replication by Blocking Viral Ribonuclease H Activity. Antimicrobial Agents and Chemotherapy. 59(2). 1070–1079. 71 indexed citations
18.
D’Erasmo, Michael P., et al.. (2014). The biology and synthesis of α-hydroxytropolones. MedChemComm. 5(7). 842–852. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inna L. Karpenko Breakdown of academic impact, for papers by David D. Deininger Breakdown of academic impact, for papers by Michael J. Bohanon Breakdown of academic impact, for papers by Ying-Kai Wang Breakdown of academic impact, for papers by Nicola Zonta Breakdown of academic impact, for papers by Massimiliano La Colla Breakdown of academic impact, for papers by Ray Ranken Breakdown of academic impact, for papers by Noreena L. Sweeney Breakdown of academic impact, for papers by Steven R. Mathieu Breakdown of academic impact, for papers by Christopher J. Yarnold
Rankless by CCL
2026